Search Results - "Parameswaran, Rekha"

High Incidence of Thromboembolic Events in Patients Treated With Cisplatin-Based Chemotherapy: A Large Retrospective Analysis by MOORE, Russell A, ADEL, Nelly, RIEDEL, Elyn, BHUTANI, Manisha, FELDMAN, Darren R, ELISE TABBARA, Nour, SOFF, Gerald, PARAMESWARAN, Rekha, HASSOUN, Hani

“…This study was designed to determine the incidence of venous and arterial thromboembolic events (TEEs) in patients treated with cisplatin-based chemotherapy…”
Get full text

Routine clinical parameters and laboratory testing predict therapy-related myeloid neoplasms after treatment for breast cancer by Petrone, Giulia, Gaulin, Charles, Derkach, Andriy, Kishtagari, Ashwin, Robson, Mark E, Parameswaran, Rekha, Stein, Eytan M

“…We aim to identify predictors of therapy-related myeloid neoplasms (t-MN) in patients with breast cancer (BC) and cytopenias to determine the timing of bone…”
Get full text

Safe and effective use of rivaroxaban for treatment of cancer-associated venous thromboembolic disease: a prospective cohort study by Mantha, Simon, Laube, Eva, Miao, Yimei, Sarasohn, Debra M., Parameswaran, Rekha, Stefanik, Samantha, Brar, Gagandeep, Samedy, Patrick, Wills, Jonathan, Harnicar, Stephen, Soff, Gerald A.

“…Low-molecular weight heparin (LMWH) has been the standard of care for treatment of venous thromboembolism (VTE) in patients with cancer. Rivaroxaban was…”
Get full text

Romiplostim for chemotherapy‐induced thrombocytopenia: Efficacy and safety of extended use by Wilkins, Cy R., Ortiz, Jocelyn, Gilbert, Leah J., Yin, Shen, Mones, Jodi V., Parameswaran, Rekha, Mantha, Simon, Soff, Gerald A.

“…Chemotherapy‐induced thrombocytopenia (CIT) is common during treatment with antineoplastic therapies and may adversely impact chemotherapy dose intensity…”
Get full text

Acquired hemophilia as the cause of life-threatening hemorrhage in a 94-year-old man: a case report by Kelesidis, Theodoros, Raphael, Jonelle, Blanchard, Elizabeth, Parameswaran, Rekha

“…Acquired factor VIII deficiency is a rare entity that can lead to severe and life-threatening bleeding. We describe a case of severe bleeding from the tongue…”
Get full text

Enoxaparin dose reduction for thrombocytopenia in patients with cancer: a quality assessment study by Mantha, Simon, Miao, Yimei, Wills, Jonathan, Parameswaran, Rekha, Soff, Gerald A.

“…The development of thrombocytopenia in the setting of therapeutic anticoagulation for venous thromboembolic disease (VTE) is common in cancer patients, but…”
Get full text

Granulocyte‐colony stimulating factor in COVID‐19: Is it stimulating more than just the bone marrow? by Nawar, Tamara, Morjaria, Sejal, Kaltsas, Anna, Patel, Dhruvkumar, Perez‐Johnston, Rocio, Daniyan, Anthony F., Mailankody, Sham, Parameswaran, Rekha

Get full text

Romiplostim Treatment of Chemotherapy-Induced Thrombocytopenia by Soff, Gerald A., Miao, Yimei, Bendheim, Gemma, Batista, Jeanette, Mones, Jodi V., Parameswaran, Rekha, Wilkins, Cy R., Devlin, Sean M., Abou-Alfa, Ghassan K., Cercek, Andrea, Kemeny, Nancy E., Sarasohn, Debra M., Mantha, Simon

“…PURPOSE Chemotherapy-induced thrombocytopenia (CIT) leads to delay or reduction in cancer treatment. There is no approved treatment. METHODS We conducted a…”
Get full text

Efficacy and Safety of Extended Use of Romiplostim Treatment for Chemotherapy-Induced Thrombocytopenia by Wilkins, Cy R, Ortiz, Jocelyn, Gilbert, Leah, Yin, Shen, Mones, Jodi V., Parameswaran, Rekha, Mantha, Simon, Soff, Gerald A.

“…Background: Chemotherapy induced thrombocytopenia (CIT) is common, adversely impacts chemotherapy relative dose intensity, and may adversely impact cancer…”
Get full text

Indications for and complications of transfusion and the management of gynecologic malignancies by Cybulska, Paulina, Goss, Cheryl, Tew, William P, Parameswaran, Rekha, Sonoda, Yukio

“…Abstract Anemia, which is highly prevalent in oncology patients, is one of the most established negative prognostic factors for several gynecologic…”
Get full text

The Effect of Neutropenia and Filgrastim (G-CSF) on Cancer Patients With Coronavirus Disease 2019 (COVID-19) Infection by Zhang, Allen W, Morjaria, Sejal, Kaltsas, Anna, Hohl, Tobias M, Parameswaran, Rekha, Patel, Dhruvkumar, Zhou, Wei, Predmore, Jacqueline, Perez-Johnston, Rocio, Jee, Justin, Daniyan, Anthony F, Perales, Miguel-Angel, Taur, Ying

“…Abstract Background Neutropenia is commonly encountered in cancer patients. Recombinant human granulocyte colony-stimulating factor (G-CSF, filgrastim), a…”
Get full text

Aspirin Is Associated with Improved Survival in Severely Thrombocytopenic Cancer Patients with Acute Myocardial Infarction by Feher, Attila, Kampaktsis, Polydoros N., Parameswaran, Rekha, Stein, Eytan M., Steingart, Richard, Gupta, Dipti

“…Background Patients with hematologic malignancies are at risk for severe thrombocytopenia (sTP). The risk and benefit of aspirin are not known in…”
Get full text

Abstract 17321: Aspirin Use is Associated With Improved Survival in Severely Thrombocytopenic Cancer Patients With Acute Myocardial Infarction by Feher, Attila, Parameswaran, Rekha, Stein, Eytan M, Gupta, Dipti

“…ObjectivePatients with hematologic malignancies are at risk for severe thrombocytopenia (sTP). The risk and benefit of aspirin therapy is not known in…”
Get full text

Romiplostim in a Case Series of Chemotherapy-Induced Thrombocytopenia by Parameswaran, Rekha, Soff, Gerald A.

“…Abstract 1170 Thrombocytopenia is a common effect of cytotoxic chemotherapy regimens in cancer patients, often necessitating reduction or delay in subsequent…”
Get full text

Corrigendum to “Indications for and complications of transfusion and the management of gynecologic malignancies” [Gynecol. Oncol. 146 (2017) 416–426] by Cybulska, Paulina, Goss, Cheryl, Tew, William P., Parameswaran, Rekha, Sonoda, Yukio

Get full text

Autoimmune Hemolysis (AH) & Immune Thrombocytopenic Purpura (ITP) after Cord Blood Transplantation (CBT) May be Life-Threatening & Warrant Early Therapy with Rituximab by Bhatt, Valkal, Pharm.D, Shune, Leyla, MD, Lauer, Emily, BS, Lubin, Marissa, BA, Devlin, Sean, PhD, Scaradavou, Andromachi, MD, Kernan, Nancy A., MD, Giralt, Sergio, MD, Parameswaran, Rekha, MD, Perales, Miguel-Angel, MD, Ponce, Doris M., MD, Soff, Gerald A., MD, Barker, Juliet, MBBS (Hons) FRACP

Get full text

Romiplostim management of chemotherapy-induced thrombocytopenia by Soff, Gerald A., Parameswaran, Rekha, Mantha, Simon, Miao, Yimei, Mones, Jodi Victoria

“…Abstract only…”
Get full text

Outcomes of Inferior Vena Cava Filter Placement in a Large Population of Cancer Patients Diagnosed with Pulmonary Embolism: Risk for Recurrent Venous Thromboembolism, Survival, and Filter-Related Complications by Coombs, Catherine C., Kuk, Deborah, Devlin, Sean, Siegelbaum, Robert, Parameswaran, Rekha, Mantha, Simon, Soff, Gerald A

“…Background: Venous thromboembolism (VTE) is a common complication in cancer patients. Anticoagulation (AC) remains the standard of care for treatment of…”
Get full text

Reduced Emergency Room Utilization for Initiation of Anticoagulation with Rivaroxaban Versus Low Molecular Weight Heparin for Treatment of Cancer-Associated Thrombosis by Soff, Aaron P, Dong, Judy, Dong, Aiqi, Devlin, Sean, Mantha, Simon, Parameswaran, Rekha, Soff, Gerald A

“…Background: Venous thromboembolism (VTE) is a leading cause of mortality and morbidity in cancer patients. The current standard of care is to treat…”
Get full text

Enoxaparin Dose Reduction for Thrombocytopenia in Patients with Cancer: A Quality Assessment Study by Miao, Yimei, Soff, Gerald A, Parameswaran, Rekha, Wills, Jonathan, Mantha, Simon

“…▪ Background: The development of chemotherapy-induced thrombocytopenia (CIT) in the setting of therapeutic anticoagulation for venous thromboembolic (VTE)…”
Get full text